Actos Bladder Cancer

We are no longer accepting Actos cases.

The risk of bladder cancer is 40 percent greater in patients taking Actos for longer than two years.

Takeda Pharmaceutical’s blockbuster diabetes drug Actos (pioglitazone) has been linked to an increased risk of bladder cancer in numerous studies, a finding that prompted both France and Germany to suspend prescription of the popular drug. In the US, the Food and Drug Administration (FDA) has warned of this potentially life threatening Actos side effect, but has not pulled the drug off the shelves. The FDA is currently conducting its own investigation into Actos bladder cancer.

Actos Bladder Cancer Lawsuit

Baum Hedlund is representing the former medical reviewer for Takeda, the United States, and 22 states, in a whistleblower lawsuit (Case 1:10-cv-11043-FDS – U.S. District Court for the District of Massachusetts) alleging that Takeda failed to properly report all Actos bladder cancer adverse events to the FDA. The firm is also representing many families in state and federal lawsuits alleging Actos caused their bladder cancer.

Data linking pioglitazone to bladder cancer was first observed by Takeda in animal studies back in 1999.

Cancer has been reported in both Actos animal studies and human clinical trials for years, placing the legal obligation on Takeda to update its Actos package insert. Takeda failed to do so, other than adding an FDA-required reference in the Actos package insert referring to the 2005 study results, showing that more participants taking Actos had developed bladder cancers. However, Takeda also inserted minimizing language stating a causal link had not been established for Actos bladder cancer.

Takeda continues to sell this potentially dangerous drug to diabetes patients at risk for bladder cancer in most countries throughout the world.

If you have taken Actos and are now suffering from Actos side effects, including Actos bladder cancer, you may be entitled to compensation. It is very important that you find experienced legal counsel to help you through this difficult time.

The law firm of Baum Hedlund Aristei & Goldman has extensive experience in litigating thousands of personal injury, wrongful death and consumer class action cases against major pharmaceutical companies over the past 25 years. The firm has been on the prevailing side of some of the nation’s most highly-publicized cases. Such litigation involves complex evidence and choice of law issues which have been routinely handled by the firm in both state and federal courts.